JIC RELEASE NO. 1100 - COVID-19 Test Results: 151 New Cases, 18 Hospitalized; Additional COVID-19 Updates

COVID-19 Test Results: 151 New Cases Reported

Today, the Department of Public Health and Social Services (DPHSS) reported 151 new cases of COVID-19 from 1,433 specimens collected July 28, 2022. Twelve (12) of the cases reported today are through the Department of Defense. To date, there have been a total of 55,208 officially reported cases, 380 deaths, 871 cases in active isolation, and 53,957 not in active isolation.

18 Hospitalized for COVID-19

SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 8 vaccinated people hospitalized for COVID-19 compared to 53 unvaccinated people hospitalized for COVID-19. The risk of being hospitalized for COVID-19 is about 7 times higher for the unvaccinated as compared to the vaccinated. *Estimated population is based on DPHSS Immunization Program analysis of 2020 Census data. Updates are expected pending further Census 2020 data breakdown.

DPHSS mAb Treatment Center Open at Paseo Stadium

Bebtelovimab, a monoclonal antibody (mAb) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) is available at the DPHSS mAb treatment center at the Paseo Stadium in Hagåtña from 9 a.m. to 4 p.m. Monday through Saturday. 

To schedule treatment at the DPHSS mAb treatment center, patients must call 671-998-4527 or 671-998-4547, have a current, laboratory confirmed COVID–19 infection and a referral from a prescribing physician. For more information about Bebtelovimab and other mAb treatment options on Guam, visit dphss.guam.gov/mab or dial 311 from a local number and select option 1 on weekdays from 8 a.m. to 9 p.m. and on weekends and holidays from 8 a.m. to 5 p.m. 
 

COVID-19 Vaccines for Children 6 Months and Older Available at DPHSS CHCs

The Moderna and the Pfizer-BioNTech COVID-19 Vaccines authorized for use in children down to six months of age. In most children, the Moderna COVID-19 vaccine for children ages six months through five years will be a two-dose primary series with four to eight weeks between dose one and dose two. In most children, the Pfizer-BioNTech COVID-19 vaccine for children ages six months through four years will be a three-dose primary series three to eight weeks between dose one and dose two, and at least eight weeks between dose two and dose three.

COVID-19 vaccination for individuals ages six months and older is available at the DPHSS Northern Region Community Health Center in Dededo, and the DPHSS Southern Region Community Health Center in Inalåhan. Requirements for minors to receive the Moderna or Pfizer-BioNTech COVID-19 Vaccine:

• Parent/legal guardian must provide minor’s birth certificate

• Parent/legal guardian must have a government-issued photo identification

• Minor must be accompanied by a parent or legal guardian

• Guardians must present legal guardianship or power-of-attorney documents

COVID-19 vaccination for individuals ages six months to 4 years of age is NOT available at the  ASC vaccination clinic.

Incentives Offered for COVID-19 Vaccination Series Completion and Boosters

A program administered by the government of Guam is providing incentives to individuals 12 years of age and older who maintain their COVID-19 vaccinations who are completing their last dose in primary series; OR receiving 1st Booster Dose OR 2nd Booster Dose

Eligible residents will be offered an incentive (alcohol and tobacco items excluded) while supplies last. Gift certificates will only be offered at vaccination clinics at NRCHC, SRCHC, the Agana Shopping Center, and senior citizen outreach clinics, while supplies last. 

Guam COVID-19 Vaccination Update

As of July 28, 2022, 139,466 eligible residents (6 months and older) are fully vaccinated. This total includes 14,306 residents 12 – 17 years old. 8,747 residents 5 – 11 years old received their first dose of a two dose series. 7,081 residents 5 – 11 years old have completed their two-dose series. 92 residents 6 months – 4 years old have received their first dose of a two dose series. 67,221 eligible residents have received their first booster shots. 10,900 eligible residents have received their second booster shots.